Structural basis for antiarrhythmic drug interactions with the human cardiac sodium channel

Area of Science:

• Cardiovascular Pharmacology
• Molecular Biophysics
• Structural Biology

Background:

• The human voltage-gated sodium channel, hNa_V1.5, is critical for cardiac action potential upstroke.
• hNa_V1.5 is a key target for antiarrhythmic drugs, yet atomic-level drug interaction mechanisms remain unclear.
• Understanding drug interactions is vital for developing improved antiarrhythmic therapies.

Purpose of the Study:

• To investigate the structure-based molecular mechanisms of antiarrhythmic and local anesthetic drug interactions with hNa_V1.5.
• To identify key drug binding sites and access pathways within the channel.
• To provide insights for the rational design of novel hNa_V1.5-targeting therapeutics.

Main Methods:

• Utilized Rosetta structural modeling and docking.
• Employed molecular dynamics simulations to study drug-channel interactions.
• Analyzed drug binding sites within the hNa_V1.5 pore lumen.

Main Results:

• Identified multiple drug binding sites within the hNa_V1.5 pore, capable of accommodating up to two molecules simultaneously.
• Characterized a hydrophilic access pathway via the intracellular gate.
• Discovered a hydrophobic access pathway through a fenestration between domains DIII and DIV.

Conclusions:

• Advanced the understanding of molecular mechanisms governing antiarrhythmic and local anesthetic drug interactions with hNa_V1.5.
• The identified binding sites and pathways offer crucial information for future drug design.
• Findings will facilitate the development of novel and improved therapeutics targeting cardiac sodium channels.